|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.920 USD | -72.61% |
|
-74.09% | -73.91% |
| 07-31 | Top Midday Decliners | MT |
| 07-31 | Baird Downgrades Karyopharm Therapeutics to Neutral From Outperform, Adjusts Price Target to $3 From $15 | MT |
| Market Cap | 43.51M 37.83M 35.21M 32.32M 61.04M 4.15B 61.99M 415M 163M 2.07B 163M 160M 6.93B | P/E 2026 * |
-0.43x | P/E 2027 * | -0.64x |
|---|---|---|---|---|---|
| Enterprise Value | 43.51M 37.83M 35.21M 32.32M 61.04M 4.15B 61.99M 415M 163M 2.07B 163M 160M 6.93B | EV / Sales 2026 * |
0.33x | EV / Sales 2027 * | 0.26x |
| Free-Float |
95.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | -72.61% | ||
| 1 week | -74.09% | ||
| 1 month | -79.90% | ||
| 3 months | -78.11% | ||
| 6 months | -70.55% | ||
| Current year | -73.91% |
| 1 week | 1.8 |  | 7.84 |
| 1 month | 1.8 | | 10.86 |
| Current year | 1.8 | | 10.99 |
| 1 year | 1.8 | | 10.99 |
| 3 years | 1.8 | | 29.25 |
| 5 years | 1.8 | | 220.95 |
| 10 years | 1.8 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 03/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 03/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 62 | 01/01/2013 |
| Director/Board Member | 61 | 01/04/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 03/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/07/26 | Sell | Executive/Senior Manager | -189 | 0.0008% | ||
| 14/05/26 | Sell | Controller/Auditor | -53 | 0.0002% | ||
| 17/02/26 | Sell | Executive/Senior Manager | 378 | 0.0021% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -72.61% | -74.09% | -51.15% | -92.89% | 43.51M | |
| +3.29% | +16.25% | +36.46% | +3.19% | 76.15B | |
| +2.72% | -9.39% | +20.58% | +172.43% | 48.89B | |
| -2.75% | +48.50% | +48.50% | +48.50% | 47.83B | |
| -3.81% | +7.74% | -53.40% | -54.31% | 41.37B | |
| -2.40% | +0.38% | +53.81% | -24.64% | 29.99B | |
| -2.82% | +1.57% | +58.12% | +87.66% | 24.23B | |
| -5.35% | +1.39% | +98.59% | -51.89% | 21.89B | |
| -1.59% | -3.61% | -6.77% | +150.58% | 19.25B | |
| -0.42% | +2.89% | +77.99% | +128.67% | 17.14B | |
| Average | -8.57% | -6.07% | +28.27% | +36.73% | 32.68B | |
| Weighted average by Cap. | -0.62% | +2.97% | +31.45% | +43.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 134M 116M 108M 99.35M 188M 12.77B 191M 1.28B 501M 6.36B 502M 491M 21.31B | 169M 147M 136M 125M 236M 16.09B 240M 1.61B 631M 8.01B 633M 619M 26.86B |
| Net income | -125M -108M -101M -92.51M -175M -11.89B -177M -1.19B -466M -5.92B -468M -457M -19.84B | -121M -105M -97.83M -89.82M -170M -11.54B -172M -1.15B -453M -5.75B -454M -444M -19.27B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $1.920 | -72.61% | 22,398,319 |
| 30/07/26 | $7.010 | +2.19% | 4,540,851 |
| 29/07/26 | $6.860 | -3.24% | 436,891 |
| 28/07/26 | $7.090 | -.--% | 531,286 |
| 27/07/26 | $7.090 | -4.32% | 527,473 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
